MedStar Health Research Institute, Washington, District of Columbia.
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
J Am Soc Echocardiogr. 2021 Sep;34(9):955-965. doi: 10.1016/j.echo.2021.04.003. Epub 2021 May 8.
Left ventricular (LV) global longitudinal strain (GLS) is a sensitive marker of LV function and may help identify patients with heart failure (HF) and secondary mitral regurgitation who would have a better prognosis and are more likely to benefit from edge-to-edge transcatheter mitral valve repair with the MitraClip. The aim of this study was to assess the prognostic utility of baseline LV GLS during 2-year follow-up of patients with HF with secondary mitral regurgitation enrolled in the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation trial.
Patients with symptomatic HF with moderate to severe or severe secondary mitral regurgitation who remained symptomatic despite maximally tolerated guideline-directed medical therapy (GDMT) were randomized to transcatheter mitral valve repair plus GDMT or GDMT alone. Speckle-tracking-derived LV GLS from baseline echocardiograms was obtained in 565 patients and categorized in tertiles. Death and HF hospitalization at 2-year follow-up were the principal outcomes of interest.
Patients with better baseline LV GLS had higher blood pressure, greater LV ejection fraction and stroke volume, lower levels of B-type natriuretic peptide, and smaller LV size. No significant difference in outcomes at 2-year follow-up were noted according to LV GLS. However, the rate of death or HF hospitalization between 10 and 24 months was lower in patients with better LV GLS (P = .03), with no differences before 10 months. There was no interaction between GLS tertile and treatment group with respect to 2-year clinical outcomes.
Baseline LV GLS did not predict death or HF hospitalization throughout 2-year follow-up, but it did predict outcomes after 10 months. The benefit of transcatheter mitral valve repair over GDMT alone was consistent in all subgroups irrespective of baseline LV GLS.
左心室(LV)整体纵向应变(GLS)是 LV 功能的敏感标志物,可帮助识别心力衰竭(HF)伴继发性二尖瓣反流患者,这些患者具有更好的预后,并且更有可能从二尖瓣夹合器经导管二尖瓣修复中获益。本研究旨在评估在心血管结局评估二尖瓣夹合器经皮治疗心力衰竭伴功能性二尖瓣反流患者的试验中,HF 伴继发性二尖瓣反流患者的 2 年随访期间基线 LV GLS 的预后价值。
症状性 HF 伴中度至重度或重度继发性二尖瓣反流患者,尽管接受了最大耐受指南导向的药物治疗(GDMT),但仍有症状,将其随机分为经导管二尖瓣修复术联合 GDMT 或 GDMT 单独治疗。565 例患者均获得基线超声心动图的斑点追踪衍生的 LV GLS,并分为三分位。2 年随访时的主要终点是死亡和 HF 住院。
基线 LV GLS 较好的患者具有较高的血压、较大的 LV 射血分数和每搏输出量、较低的 B 型利钠肽水平和较小的 LV 大小。根据 LV GLS,在 2 年随访时未观察到结局有显著差异。然而,在基线后 10-24 个月时,LV GLS 较好的患者死亡率或 HF 住院率较低(P = 0.03),在 10 个月之前无差异。GLS 三分位与治疗组之间在 2 年临床结局方面无交互作用。
基线 LV GLS 不能预测 2 年随访期间的死亡或 HF 住院,但能预测 10 个月后的结局。与 GDMT 单独治疗相比,经导管二尖瓣修复术的获益在所有亚组中是一致的,与基线 LV GLS 无关。